Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224


Epitope mapping by random peptide phage display reveals essential residues for vaccinia extracellular enveloped virion spread.

He Y, Wang Y, Struble EB, Zhang P, Chowdhury S, Reed JL, Kennedy M, Scott DE, Fisher RW.

Virol J. 2012 Sep 24;9:217. doi: 10.1186/1743-422X-9-217.


Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.

Paran N, Lustig S, Zvi A, Erez N, Israely T, Melamed S, Politi B, Ben-Nathan D, Schneider P, Lachmi B, Israeli O, Stein D, Levin R, Olshevsky U.

Virol J. 2013 Jul 10;10:229. doi: 10.1186/1743-422X-10-229.


Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model.

Chen Z, Earl P, Americo J, Damon I, Smith SK, Yu F, Sebrell A, Emerson S, Cohen G, Eisenberg RJ, Gorshkova I, Schuck P, Satterfield W, Moss B, Purcell R.

J Virol. 2007 Sep;81(17):8989-95. Epub 2007 Jun 20.


Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.

Kaever T, Matho MH, Meng X, Crickard L, Schlossman A, Xiang Y, Crotty S, Peters B, Zajonc DM.

J Virol. 2016 Apr 14;90(9):4334-45. doi: 10.1128/JVI.02878-15. Print 2016 May.


Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine.

Golden JW, Hooper JW.

Virology. 2008 Jul 20;377(1):19-29. doi: 10.1016/j.virol.2008.04.003. Epub 2008 May 14.


Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer.

Matho MH, Schlossman A, Meng X, Benhnia MR, Kaever T, Buller M, Doronin K, Parker S, Peters B, Crotty S, Xiang Y, Zajonc DM.

PLoS Pathog. 2015 Sep 1;11(9):e1005148. doi: 10.1371/journal.ppat.1005148. eCollection 2015 Sep.


Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.

Golden JW, Zaitseva M, Kapnick S, Fisher RW, Mikolajczyk MG, Ballantyne J, Golding H, Hooper JW.

Virol J. 2011 Sep 20;8:441. doi: 10.1186/1743-422X-8-441.


Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.

Aldaz-Carroll L, Whitbeck JC, Ponce de Leon M, Lou H, Hirao L, Isaacs SN, Moss B, Eisenberg RJ, Cohen GH.

J Virol. 2005 May;79(10):6260-71.


An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies.

Xu C, Meng X, Yan B, Crotty S, Deng J, Xiang Y.

Virology. 2011 Sep 15;418(1):67-73. doi: 10.1016/j.virol.2011.06.029. Epub 2011 Aug 2.


Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.

Meseda CA, Campbell J, Kumar A, Garcia AD, Merchlinsky M, Weir JP.

PLoS One. 2013 Jun 13;8(6):e67984. doi: 10.1371/journal.pone.0067984. Print 2013.


Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in L1 protein.

Kaever T, Meng X, Matho MH, Schlossman A, Li S, Sela-Culang I, Ofran Y, Buller M, Crump RW, Parker S, Frazier A, Crotty S, Zajonc DM, Peters B, Xiang Y.

J Virol. 2014 Oct;88(19):11339-55. doi: 10.1128/JVI.01491-14. Epub 2014 Jul 16.


Identification of a conserved linear B-cell epitope at the N-terminus of the E2 glycoprotein of Classical swine fever virus by phage-displayed random peptide library.

Peng WP, Hou Q, Xia ZH, Chen D, Li N, Sun Y, Qiu HJ.

Virus Res. 2008 Aug;135(2):267-72. doi: 10.1016/j.virusres.2008.04.003. Epub 2008 May 15.


Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.

Babas T, Le Grand R, Dormont D, Bahraoui E.

AIDS Res Hum Retroviruses. 1997 Sep 1;13(13):1109-19.


Identification of a conserved B-cell epitope on reticuloendotheliosis virus envelope protein by screening a phage-displayed random peptide library.

Xue M, Shi X, Zhang J, Zhao Y, Cui H, Hu S, Gao H, Cui X, Wang YF.

PLoS One. 2012;7(11):e49842. doi: 10.1371/journal.pone.0049842. Epub 2012 Nov 21.


Fine mapping of a linear epitope on EDIII of Japanese encephalitis virus using a novel neutralizing monoclonal antibody.

Deng WL, Guan CY, Liu K, Zhang XM, Feng XL, Zhou B, Su XD, Chen PY.

Virus Res. 2014 Jan 22;179:133-9. doi: 10.1016/j.virusres.2013.10.022. Epub 2013 Oct 31.


Epitope mapping by phage display: random versus gene-fragment libraries.

Fack F, Hügle-Dörr B, Song D, Queitsch I, Petersen G, Bautz EK.

J Immunol Methods. 1997 Aug 7;206(1-2):43-52.


Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement.

Benhnia MR, McCausland MM, Moyron J, Laudenslager J, Granger S, Rickert S, Koriazova L, Kubo R, Kato S, Crotty S.

J Virol. 2009 Feb;83(3):1201-15. doi: 10.1128/JVI.01797-08. Epub 2008 Nov 19.


Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis.

Kola A, Baensch M, Bautsch W, Hennecke M, Klos A, Casaretto M, Köhl J.

Immunotechnology. 1996 Jun;2(2):115-26.


Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay.

Lin HE, Tsai WY, Liu IJ, Li PC, Liao MY, Tsai JJ, Wu YC, Lai CY, Lu CH, Huang JH, Chang GJ, Wu HC, Wang WK.

PLoS Negl Trop Dis. 2012 Jan;6(1):e1447. doi: 10.1371/journal.pntd.0001447. Epub 2012 Jan 3.


Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides.

Coley AM, Campanale NV, Casey JL, Hodder AN, Crewther PE, Anders RF, Tilley LM, Foley M.

Protein Eng. 2001 Sep;14(9):691-8.


Supplemental Content

Support Center